izpis_h1_title_alt

Simple HPLC-UV method for therapeutic drug monitoring of 12 antiepileptic drugs and their main metabolites in human plasma
ID Milosheska, Daniela (Author), ID Roškar, Robert (Author)

.pdfPDF - Presentation file, Download (1,44 MB)
MD5: 6F72B0E91D003E7D14C18E4A7AABE89A
URLURL - Source URL, Visit https://www.mdpi.com/1420-3049/28/23/7830 This link opens in a new window

Abstract
The objective of the present report was to develop and validate a simple, selective, and reproducible high-performance liquid chromatography method with UV detection suitable for routine therapeutic drug monitoring of the most commonly used antiepileptic drugs and some of their metabolites. Simple precipitation of plasma proteins with acetonitrile was used for sample preparation. 10,11-dihydrocarbamazepine was used as an internal standard. Chromatographic separation of the analytes was achieved by gradient elution on a Phenyl–Hexyl column at 40 °C, using methanol and potassium phosphate buffer (25 mM; pH 5.1) as a mobile phase. The method was validated according to the FDA guidelines for bioanalytical method validation. It showed to be selective, accurate, precise, and linear over the concentration ranges of 1–50 mg/L for phenobarbital, phenytoin, levetiracetam, rufinamide, zonisamide, and lacosamide; 0.5–50 mg/L for lamotrigine, primidone, carbamazepine and 10-monohydroxycarbazepine; 0.2–10 mg/L for carbamazepine metabolites: 10,11-trans-dihydroxy-10,11-dihydrocarbamazepine and carbamazepine-10,11-epoxide; 0.1–10 mg/L for oxcarbazepine; 2–100 mg/L for felbamate and 3–150 mg/L for ethosuximide. The suitability of the validated method for routine therapeutic drug monitoring was confirmed by quantification of the analytes in plasma samples from patients with epilepsy on combination antiepileptic therapy.

Language:English
Keywords:antiepileptic drugs, human plasma, therapeutic drug monitoring, bioanalytical method validation, high-performance liquid chromatography
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:15 str.
Numbering:Vol. 28, iss. 23, art. 7830
PID:20.500.12556/RUL-152740 This link opens in a new window
UDC:543.544.5:616.853
ISSN on article:1420-3049
DOI:10.3390/molecules28237830 This link opens in a new window
COBISS.SI-ID:174900739 This link opens in a new window
Publication date in RUL:05.12.2023
Views:324
Downloads:15
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Molecules
Shortened title:Molecules
Publisher:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:antiepileptična zdravila, človeška plazma, terapevtsko spremljanje zdravil, validacija bioanalitskih metod, tekočinska kromatografija visoke ločljivosti, epilepsija

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0189
Name:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Funder:Other - Other funder or multiple funders
Funding programme:AD Futura Science and Education Foundation of the Republic of Slovenia

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back